HempNewsBreaks – MCTC Holdings, Inc. (MCTC) Releases CEO Shareholder Letter, Strategic Direction for 2020

MCTC Holdings (OTC: MCTC) today provided a letter to its shareholders to recap 2019 and provide an overview of the company’s plans moving into 2020. Among the topics covered, the letter discussed the company’s reorganization with a new management team led by Arman Tabatabaei, as well as installation of an experienced board of directors. The letter also covered the company’s current strategic direction to re-position in the cannabinoid sciences arena. “It is our team’s strong belief that one of the most underserved submarkets of the hemp and cannabis marketplaces relates to the delivery of hemp extracts and cannabinoids to the human body. The Farm Bill of 2018, which made hemp legal at the federal level, is now one year old. Prior to this time, it had generally been illegal for scientists and researchers to possess hemp extracts, thus there had been very little research accomplished,” MCTC CEO Arman Tabatabaei stated in the letter. “The passage of the Farm Bill has now opened up numerous areas of research for MCTC, and others, to pursue relative to developing the best methods and sciences relating to administering hemp extracts and cannabinoids to the human body. We have hit the ground running in the area, which is generally being identified as the cannabinoid sciences sub-sector of the cannabis and hemp marketplaces.”

To view the full press release, visit http://cnw.fm/GS7rw

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. More information on the Company can be viewed at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

Leave a Reply